MRK
Price
$109.73
Change
+$0.33 (+0.30%)
Updated
Oct 11 closing price
18 days until earnings call
NVS
Price
$116.22
Change
+$1.41 (+1.23%)
Updated
Oct 11 closing price
16 days until earnings call
Ad is loading...

MRK vs NVS

Header iconMRK vs NVS Comparison
Open Charts MRK vs NVSBanner chart's image
Merck & Co
Price$109.73
Change+$0.33 (+0.30%)
Volume$8.58M
CapitalizationN/A
Novartis AG
Price$116.22
Change+$1.41 (+1.23%)
Volume$1.1M
CapitalizationN/A
View a ticker or compare two or three
MRK vs NVS Comparison Chart
Loading...
MRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MRK vs. NVS commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a StrongSell and NVS is a StrongBuy.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (MRK: $109.73 vs. NVS: $116.22)
Brand notoriety: MRK: Notable vs. NVS: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 97% vs. NVS: 109%
Market capitalization -- MRK: $331.75B vs. NVS: $197.93B
MRK [@Pharmaceuticals: Major] is valued at $331.75B. NVS’s [@Pharmaceuticals: Major] market capitalization is $197.93B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 3 FA rating(s) are green whileNVS’s FA Score has 3 green FA rating(s).

  • MRK’s FA Score: 3 green, 2 red.
  • NVS’s FA Score: 3 green, 2 red.
According to our system of comparison, NVS is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 4 TA indicator(s) are bullish while NVS’s TA Score has 6 bullish TA indicator(s).

  • MRK’s TA Score: 4 bullish, 5 bearish.
  • NVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NVS is a better buy in the short-term than MRK.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а -0.04% price change this week, while NVS (@Pharmaceuticals: Major) price change was +1.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

MRK is expected to report earnings on Feb 04, 2025.

NVS is expected to report earnings on Jan 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than NVS($198B). MRK has higher P/E ratio than NVS: MRK (935.64) vs NVS (23.38). NVS YTD gains are higher at: 19.501 vs. MRK (2.577). NVS has higher annual earnings (EBITDA): 18.3B vs. MRK (6.91B). NVS has more cash in the bank: 14B vs. MRK (7.09B). NVS has less debt than MRK: NVS (26.3B) vs MRK (35.1B). MRK has higher revenues than NVS: MRK (60.1B) vs NVS (46.7B).
MRKNVSMRK / NVS
Capitalization332B198B168%
EBITDA6.91B18.3B38%
Gain YTD2.57719.50113%
P/E Ratio935.6423.384,001%
Revenue60.1B46.7B129%
Total Cash7.09B14B51%
Total Debt35.1B26.3B133%
FUNDAMENTALS RATINGS
MRK vs NVS: Fundamental Ratings
MRK
NVS
OUTLOOK RATING
1..100
5975
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
169
SMR RATING
1..100
2928
PRICE GROWTH RATING
1..100
6148
P/E GROWTH RATING
1..100
9881
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (16) in the Pharmaceuticals Major industry is in the same range as NVS (16). This means that MRK’s stock grew similarly to NVS’s over the last 12 months.

NVS's Profit vs Risk Rating (9) in the Pharmaceuticals Major industry is in the same range as MRK (16). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

NVS's SMR Rating (28) in the Pharmaceuticals Major industry is in the same range as MRK (29). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

NVS's Price Growth Rating (48) in the Pharmaceuticals Major industry is in the same range as MRK (61). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

NVS's P/E Growth Rating (81) in the Pharmaceuticals Major industry is in the same range as MRK (98). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKNVS
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
37%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
49%
MACD
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 26 days ago
48%
Bullish Trend 18 days ago
47%
Declines
ODDS (%)
Bearish Trend 5 days ago
46%
Bearish Trend 5 days ago
42%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
25%
View a ticker or compare two or three
Ad is loading...
MRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

MRK and

Correlation & Price change

A.I.dvisor tells us that MRK and AZN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRK and AZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+0.30%
AZN - MRK
31%
Poorly correlated
+0.62%
GSK - MRK
24%
Poorly correlated
-0.97%
SNY - MRK
23%
Poorly correlated
+0.35%
JNJ - MRK
22%
Poorly correlated
+0.59%
NVS - MRK
22%
Poorly correlated
+1.23%
More

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with AZN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+1.23%
AZN - NVS
48%
Loosely correlated
+0.62%
GSK - NVS
42%
Loosely correlated
-0.97%
RHHBY - NVS
38%
Loosely correlated
+0.80%
SNY - NVS
37%
Loosely correlated
+0.35%
ABBV - NVS
35%
Loosely correlated
-0.08%
More